/GDBYF
GDBYF Stock - Goodbody Health Limited
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GDBYF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta9.86
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $17.06M | $1.99M | $1.45M | $452,423 | N/A |
| Gross Profit | $8.93M | $1.12M | $754,197 | N/A | N/A |
| Gross Margin | 52.4% | 56.4% | 52.0% | 0.0% | N/A |
| Operating Income | $-1,057,000 | $-4,466,000 | $-3,320,000 | $-176,000 | $-14,133.854 |
| Net Income | $-2,314,000 | $-4,659,000 | $-3,798,000 | $-349,000 | $-175,460.503 |
| Net Margin | -13.6% | -233.7% | -262.1% | -77.1% | N/A |
| EPS | $-0.07 | $-0.29 | $-0.48 | $-0.17 | $-0.18 |
Company Overview
Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom. The company also operates as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. It has interests in COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs. The company was formerly known as Sativa Wellness Group Inc. and changed its name to Goodbody Health Inc. in January 2022. The company is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GDBYFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.03
Q3 2022
EPS Surprise History
Q2 20
No data
Q3 20
No data
Q1 21
No data
Q2 21
No data
Q3 21
No data
Q2 22
No data
Q3 22
No data
Q3 22
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2022 | Sep 30, 2022 | — | $-0.03 | — | — |
Q3 2022 | Aug 19, 2022 | — | $-0.02 | — | — |
Q2 2022 | May 25, 2022 | — | $-0.01 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.03 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.03 | — | — |
Q2 2020 | Apr 30, 2020 | — | $-0.89 | — | — |
Q1 2020 | Jan 31, 2020 | — | $-0.09 | — | — |
Q4 2019 | Oct 31, 2019 | — | $-0.09 | — | — |
Q2 2019 | Apr 30, 2019 | — | $-1.00 | — | — |
Q1 2019 | Jan 31, 2019 | — | $-0.02 | — | — |
Q4 2018 | Oct 31, 2018 | — | $-0.08 | — | — |
Q2 2018 | Apr 30, 2018 | — | $-0.01 | — | — |
Q1 2018 | Jan 31, 2018 | — | $-0.01 | — | — |
Q4 2017 | Oct 31, 2017 | — | $-0.00 | — | — |
Q2 2017 | Apr 30, 2017 | — | $-0.00 | — | — |
Q1 2017 | Jan 31, 2017 | — | $-0.00 | — | — |
Q4 2016 | Oct 31, 2016 | — | $-0.00 | — | — |
Q3 2016 | Jul 31, 2016 | — | $-0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GDBYF
What is GDBYF's current stock price?
Goodbody Health Limited (GDBYF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for GDBYF?
No analyst price targets are currently available for this stock.
What sector is Goodbody Health Limited in?
Goodbody Health Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is GDBYF's market cap?
Goodbody Health Limited has a market capitalization of $0.00 billion, making it a small-cap company.
Does GDBYF pay dividends?
No, Goodbody Health Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACCA
Acacia Diversified Holdings, Inc.
$0.00
Mkt Cap: $0.0B
ACORQ
Acorda Therapeutics, Inc.
$0.01
Mkt Cap: $0.0B
CBDHF
Hempfusion Wellness Inc.
$0.00
Mkt Cap: $0.0B
CHCR
Advanzeon Solutions, Inc.
$0.00
Mkt Cap: $0.0B
GENN
Genesis Healthcare, Inc.
$0.00
Mkt Cap: $0.0B
GNBT
Generex Biotechnology Corporation
$0.00
0MGFRF
MagForce AG
$0.00
Mkt Cap: $0.0B
NAVB
Navidea Biopharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
NNMX
Nanomix Corporation
$0.00
Mkt Cap: $0.0B
NWYU
New You, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to GDBYF for comparison